| Oct 25 |
AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND
|
| Oct 25 |
Amgen Likely to See Q3 Miss, Long-Term Positive Revenue Growth, Oppenheimer Says
|
| Oct 25 |
Stocks to watch next week: BP, Shell, Uber, HSBC and Intel
|
| Oct 25 |
What Lies in Store for Healthcare ETFs in Q3 Earnings?
|
| Oct 25 |
Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
|
| Oct 25 |
Ahead of Amgen (AMGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
| Oct 25 |
GSK invests $800M in manufacturing; Amgen sets small discount for Eylea biosimilar
|
| Oct 24 |
AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS
|
| Oct 24 |
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
| Oct 23 |
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
|
